4//SEC Filing
Chen Hongming 4
Accession 0001415889-21-003261
CIK 0001479419other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:26 PM ET
Size
4.9 KB
Accession
0001415889-21-003261
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Sale
Common Stock
2021-06-28$5.77/sh−2,452$14,148→ 240,563 total
Footnotes (2)
- [F1]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
- [F2]Includes 91,666 unvested RSUs.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710697
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:26 PM ET
- Size
- 4.9 KB